Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MS Technology Develops into an Accessible Platform

By Labmedica staff writers
Posted on 10 Jun 2008
Mass spectrometry (MS), which was until recently a complicated technology available exclusively to highly trained experts, is today a workhorse analytic technique for a wide variety of scientific applications including food and environmental contamination testing, forensic analysis, drug discovery and development, and basic research.

The development of this MS technology into an accessible platform for scientists across disciplines was the focus for Applied Biosystems (Warrington, UK) and its joint venture partner, MDS Analytical Technologies (Sunnyvale, CA, USA) during the 56th annual American Society of Mass Spectrometry (ASMS) conference in Denver, May 31-June 5, 2008.

Applied Biosystems/MDS Analytical Technologies' scientists presented more than 70 presentations highlighting recent and ongoing investigations enabled by their technology platforms at the meeting. More...
The presentations illustrated how newly released software applications and chemical reagents deliver complete, integrated workflows for applications ranging from the discovery, validation, and verification of biomarkers to drug metabolism studies, and the detection and measurement of environmental contaminants.

At the meeting Ethan Badman, Ph.D., principal scientist at Hoffman-La Roche (Nutley, NJ, USA) described a new, automated method using MS that allows a one-touch approach to determining matrix factors. Calculation of matrix factors provides a clear understanding of the matrix effects in bioanalytical assays. "The procedure developed by Applied Biosystems essentially lets us open a template, click, and get the matrix factors we need,” said Dr. Badman. "It is much easier because it is all automated, compared to calculating matrix factors manually. The fact that the algorithm is built-in reduces calculation errors.”

Christie Hunter, Ph.D., a senior staff scientist at Applied Biosystems, reviewed how the joint venture's integration of hardware, software, and reagents could be used to reproducibly quantitate hundreds of proteins for targeted proteomics applications, including biomarker studies. This extends the targeted proteomics approach, which is being called the fourth generation of proteomics.

Applied Biosystems hosted a number of workshops, including one that concentrated on the value of integrated services for validation and remote system monitoring for regulated laboratories. This workshop provided an overview of the U.S. Food and Drug Administration's trends for laboratory compliance, and highlighted the availability of an expanded range of Smart Monitoring and Compliance services from Applied Biosystems Global Services.

Applied Biosystems/MDS Analytical Technologies' expanded suite of powerful mass spectrometry software and solutions to increase scientific productivity were also on display during the meeting.


Related Links:
Applied Biosystems
MDS Analytical Technologies
Hoffman-La Roche

New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.